IP Library Granted Patent US 7,556,649
Granted Patent B2
US 7,556,649 · App. 10/812,268 · Granted Jul 7, 2009

Methods and compositions for treating intervertebral disc degeneration

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,556,649
App. No.
10/812,268
Granted
Jul 7, 2009
Kind
B2
Abstract

A fluid matrix comprising cross-linked remodelable collagen from a donor vertebrate animal is useful for regenerating hydrodynamic function in damaged intervertebral discs in vivo. The matrix may be injectable and may comprise cells and a plurality of purified cell growth factors. The matrix promotes cell growth and elaboration of proteoglycans to facilitate regeneration of native tissues. The collagen in the matrix may be cross-linked using photooxidative catalysis and visible light, and purified cell growth factors are preferably at least partly bone-derived.

Claims (27)

1. A method of manufacturing an intervertebral disc implant, comprising:

obtaining nucleus pulposus tissue harvested from a donor; and

cross linking at least a portion of the harvested nucleus pulposus tissue, wherein the nucleus pulposus tissue includes an extracellular matrix component harvested from the donor.

2. The method of claim 1 wherein the donor of the harvested nucleus pulposus tissue is xenogenic to a recipient of the intervertebral disc implant.

3. The method of claim 1 further comprising decellularizing at least a portion of the harvested nucleus pulposus tissue.

4. The method of claim 1 further comprising denaturing at least a portion of the harvested nucleus pulposus tissue.

5. The method of claim 4 wherein the denatured portion comprises proteins.

6. The method of claim 1 further comprising degrading at least a portion of the harvested nucleus pulposus tissue.

7. The method of claim 6 wherein the degraded portion comprises nucleic acids.

8. The method of claim 1 further comprising extracting at least a portion of the harvested nucleus pulposus tissue.

9. The method of claim 8 wherein the extracted portion comprises lipids.

10. The method of claim 1 wherein obtaining comprises aseptic dissection of a donor intervertebral disc.

11. The method of claim 1 wherein the cross linked portion comprises at least one protein of the harvested nucleus pulposus tissue.

12. The method of claim 11 wherein the cross linked portion comprises collagen.

13. The method of claim 1 wherein the cross linking is photo mediated.

14. The method of claim 1 wherein cross linking comprises contacting at least a portion of the harvested nucleus pulposus with a photo active dye.

15. The method of claim 14 wherein the photo active dye comprises methylene blue.

16. The method of claim 1 further comprising lyophilizing the harvested nucleus pulposus tissue.

17. The method of claim 1 further comprising pulverizing the harvested nucleus pulposus tissue.

18. The method of claim 1 further comprising sterilizing the harvested nucleus pulposus tissue.

19. The method of claim 1 further comprising disposing the harvested nucleus pulposus tissue in an injection device.

20. The method of claim 1 , further comprising combining the harvested nucleus pulposus tissue with an intervertebral disc regenerating material.

21. The method of claim 20 wherein the intervertebral disc regenerating material comprises at least one growth factor or at least one cell.

22. The method of claim 21 wherein the at least one cell is obtained from a recipient of the intervertebral disc implant.

23. The method of claim 1 , wherein the extracellular matrix component comprises a proteoglycan.

24. The method of claim 1 , wherein the extracellular matrix component comprises a protein.

25. The method of claim 24 , wherein the protein comprises collagen.

Assignments (1)
CHANGE OF NAME Recorded Feb 2, 2005
From: CENTERPULSE BIOLOGICS INC.
To: ZIMMER ORTHOBIOLOGICS, INC.
Reel/Frame 015819/0707 →